Alterity Therapeutics Ltd • ATHE

Capital at risk.

About Alterity Therapeutics Ltd
Ticker
info
ATHE
Trading on
info
NASDAQ
ISIN
info
US02155X1063
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
-
Headquarters
info
350 Collins Street, Melbourne, VIC, Australia, 3000
Employees
info
10
Website
info
https://alteritytherapeutics.com
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.
Metrics
BasicAdvanced
Market cap
info
$34.3M
P/E ratio
info
-
EPS
info
-$1.47
Dividend Yield
info
0.00%
Beta
info
0.71
Forward P/E ratio
info
0
EBIDTA
info
$-20.5M
Ex dividend date
info
-
Price & volume
Market cap
info
$34.3M
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
9.21
Price to book
info
7.02
Earnings
EPS
info
-$1.47
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-20.5M
Revenues (TTM)
info
$3.7M
Revenues per share (TTM)
info
$0.60
Technicals
Beta
info
0.71
52-week High
info
$5.87
52-week Low
info
$1.00
50-day moving average
info
$3.76
200-day moving average
info
$2.29
Short ratio
info
2.22
Short %
info
0.40%
Management effectiveness
ROE (TTM)
info
155.77%
ROA (TTM)
info
78.37%
Profit margin
info
0.00%
Gross profit margin
info
$3.5M
Operating margin
info
469.68%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
15.50%
Share stats
Outstanding Shares
info
10.7M
Float
info
3.84B
Insiders %
info
-
Institutions %
info
0.83%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$11.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.01
-
-
Q3 • 10Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0.8M
$-3.6M
446.68%
Q3 • 24
$0.8M
$-3.6M
446.68%
Q4 • 24
0.00%
0.00%
0.00%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$10.5M
$2.8M
26.18%
Q3 • 24
$10.5M
$2.8M
26.18%
Q4 • 24
0.00%
0.00%
0.00%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-4.2M
-
$0.1M
$-4.2M
Q3 • 24
$-4.2M
-
$0.1M
$-4.2M
Q4 • 24
-
-
0.00%
0.00%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Alterity Therapeutics Ltd share?
Collapse

Alterity Therapeutics Ltd shares are currently traded for undefined per share.

How many shares does Alterity Therapeutics Ltd have?
Collapse

Alterity Therapeutics Ltd currently has 10.7M shares.

Does Alterity Therapeutics Ltd pay dividends?
Collapse

No, Alterity Therapeutics Ltd doesn't pay dividends.

What is Alterity Therapeutics Ltd 52 week high?
Collapse

Alterity Therapeutics Ltd 52 week high is $5.87.

What is Alterity Therapeutics Ltd 52 week low?
Collapse

Alterity Therapeutics Ltd 52 week low is $1.00.

What is the 200-day moving average of Alterity Therapeutics Ltd?
Collapse

Alterity Therapeutics Ltd 200-day moving average is $2.29.

Who is Alterity Therapeutics Ltd CEO?
Collapse

The CEO of Alterity Therapeutics Ltd is -.

How many employees Alterity Therapeutics Ltd has?
Collapse

Alterity Therapeutics Ltd has 10 employees.

What is the market cap of Alterity Therapeutics Ltd?
Collapse

The market cap of Alterity Therapeutics Ltd is $34.3M.

What is the P/E of Alterity Therapeutics Ltd?
Collapse

The current P/E of Alterity Therapeutics Ltd is null.

What is the EPS of Alterity Therapeutics Ltd?
Collapse

The EPS of Alterity Therapeutics Ltd is -$1.47.

What is the PEG Ratio of Alterity Therapeutics Ltd?
Collapse

The PEG Ratio of Alterity Therapeutics Ltd is null.

What do analysts say about Alterity Therapeutics Ltd?
Collapse

According to the analysts Alterity Therapeutics Ltd is considered a buy.